Title
Category
Credits
Event date
Cost
Parkinson's Disease Psychosis: Review of Neuropsychiatric Complications
  • Parkinson Disease
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
An average of 35% of patients diagnosed with Parkinson’s disease experience Parkinson’s psychosis. Recognition and diagnosis of this nonmotor manifestation is critical in choosing the best treatment strategy and managing these symptoms.
Evidence-Based Treatment and Monitoring Strategies for Dementia-Related Psychosis
  • Alzheimer Disease
  • Antipsychotics
  • Dementia
  • Geriatric Psychiatry
  • Neurology
  • Parkinson Disease
  • Psychotic Disorders
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
Antipsychotics can be used in the short-term to manage dementia-related psychosis, but serious adverse effects can outweigh benefits. Novel antipsychotics or other agents may offer superior efficacy and safety. Explore the evidence in this CME activity.